THE PROBLEM OF OBESITY IN THE NHS ALL COMES DOWN TO COST.A letter to the editor is presented in response to an article by Simon Stevens in the August 20th and August 27th issues that were concerned with obese nurses in Great Britain's National Health Service.Salter...
The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation. Health Technol Assess 2009;13:1-190,215-357,iii-iv. doi: 10.3310/hta13410 pmid:19726018 . 返回引文位置Google Scholar 百度学术 万方数据 [9] Marsh K ...
Media grossly overestimates the level and cost of obesity Exaggerating numbers of overweight people is great for the diet industry, bad for people ByJacky JonesMon Feb 06 2017 - 06:00 Married women more likely to have abortions, assembly hears ...
Obesity is the UK's most prevalent antenatal comorbidity, and reducing rates of maternal obesity and risk management of complications in pregnancy and labour is a priority for the NHS. The emphasis on managing maternal obesity-related ri... M Ahluwalia - 《British Journal of Midwifery》 被引量...
Over the next few decades – as the OBR itself admits, the average low-skilled migrant labourer will cost the taxpayer £465,000 by the time they reach the age of 81. December 10, 2024 | Rue Grewal | Comment Rue Grewal: Why don’t we care enough for those who care for family with...
Thousands of people with severe obesity are being denied access to effective treatment because the NHS rollout of the weight loss jab Wegovy is happening far more slowly than planned, research by Sky News shows. Freedom of Information requests reveal that just 800 people had bee...
"The newest obesity medicines have the potential to help patients lose significant amounts of weight and reduce related conditions, but it's vital they are used alongside diet, physical activity, and wider behavioural support to help stop people regaining weight," he said. ...
Cost-effectiveness analyses of antiviral treatment for ... M Backx,A Lewszuk,JR White,... - 《Journal of Viral Hepatitis》 被引量: 26发表: 2013年 Autologous augmentation-mastopexy after bariatric surgery: waste not want not! Background The escalating trend in obesity is having major impact ...
country in Europe; an obese patient costs the NHS twice as much to treat as one who is not. The government needs a more muscular strategy to tackle this problem before it turns up in waiting rooms and hospital beds, for example by making effective use of promising new anti-obesity drugs....
A drug from Ipsen used to treat severe diarrhoea associated with a rare kind of tumour was among a group of medicines recommended for NHS funding by Scotland’s cost regulator this month.